Fast Market Research

New Market Research Report: Global Veterinary Vaccines Market 2017-2021

Fast Market Research announces the availability of the new TechNavio report, "Global Veterinary Vaccines Market 2017-2021", on their comprehensive research portal

 

Boston, MA -- (SBWIRE) -- 05/24/2017 -- Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens. The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock products like meat, milk, and other products is increasing, and the mortality rate associated with infection transmission from animals to humans through these products is alarming. These factors are driving the vendors to invest in R&D to improve and expand their product portfolios, thereby driving the market growth.

Technavio's analysts forecast the global veterinary vaccines market to grow at a CAGR of 4.81% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global veterinary vaccines market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

Get More Details on this Report and a Full Table of Contents at Global Veterinary Vaccines Market 2017-2021

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Technavio's report, Global Veterinary Vaccines Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-Elanco
-Merck
-Merial
-Zoetis

Other prominent vendors

-Advaxis
-AmpliPhi Biosciences
-Aratana Therapeutics
-ARKO Labs
-Bayer
-CanFel Therapeutics
-Ceva Animal Health
-Colorado Serum Company
-Epitopix
-Genus
-Hygieia Biological Laboratories
-ImmuCell
-Nexvet
-Nuovo Biologics
-UBI
-Valneva
-Vetoquinol
-Virbac

Market driver

-Dependency on livestock products.
-For a full, detailed list, view our report

Market challenge

-Manufacturing and storage issues.
-For a full, detailed list, view our report

Market trend

-Robust R&D and improved product portfolio.
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2021 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: Elanco, Merck, Merial, Zoetis, Advaxis, AmpliPhi Biosciences, Aratana Therapeutics, ARKO Labs, Bayer, CanFel Therapeutics, Ceva Animal Health, Colorado Serum Company, Epitopix, Genus, Hygieia Biological Laboratories, ImmuCell, Nexvet, Nuovo Biologics, UBI, Valneva, Vetoquinol, Virbac

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:
-Veterinary/Animal Vaccines Market - Forecast to 2021
-Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19
-PharmaPoint: Meningococcal Vaccines - Global Drug Forecast and Market Analysis to 2025
-PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2025
-Global H1N1 Vaccines Market 2016-2020